| JPM GLOBAL HEALTHCARE I (ACC) USD | RVI SALUD | 27,54% | 38,03% | 26,48% | 171,90% |
| GOLDMAN SACHS GLOBAL SMALL CAP CORE EQUITY PORTFOLIO E (SNAP) EUR CAP | RVI GLOBAL SMALL/MID CAP | 21,35% | 66,80% | 53,21% | 171,87% |
| MFS MERIDIAN EUROPEAN RESEARCH FUND WH1-GBP | RVI EUROPA | 25,04% | 59,94% | 48,92% | 171,87% |
| POLAR CAPITAL HEALTHCARE OPPORTUNITIES R USD DIS | RVI SALUD | 9,92% | 45,52% | 34,00% | 171,80% |
| BNP PARIBAS HEALTH CARE INNOVATORS I EUR CAP | RVI SALUD | 17,48% | 42,58% | 39,32% | 171,76% |
| HSBC GIF FRONTIER MARKETS BC USD | RVI EMERGENTES | 8,58% | 58,58% | 83,64% | 171,73% |
| BNY MELLON LONG-TERM GLOBAL EQUITY FUND EURO W (ACC) | RVI GLOBAL | 11,31% | 31,91% | 27,09% | 171,66% |
| BGF WORLD HEALTHSCIENCE A2 USD | RVI BIOTECNOLOGÍA | 27,03% | 35,40% | 35,77% | 171,59% |
| MAN JAPAN COREALPHA EQUITY I SEK | RVI JAPÓN | 33,78% | 76,84% | 115,01% | 171,57% |
| JPM GLOBAL HEALTHCARE C (ACC) EUR | RVI SALUD | 27,41% | 38,24% | 26,47% | 171,52% |
